| Literature DB >> 21358340 |
Neil J Rawlinson1, Bonita Fung, Thomas G Gross, Amanda M Termuhlen, Micah Skeens, Amy Garee, Sandeep Soni, Daniel Pietryga, Rajinder P S Bajwa.
Abstract
Matched sibling donor hematopoietic stem cell transplantation is the standard of care for severe aplastic anemia, with an overall survival of 80% to 90%. Only 60% to 70% of patients respond to treatment with immunosuppressive therapy. The main life threatening complications are infections, graft failure, and graft versus host disease. A 10-year-old patient with severe aplastic anemia underwent matched sibling donor hematopoietic stem cell transplantation, but developed sudden onset of fatal multiorgan failure on day +12. The cause of death was found only after autopsy.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21358340 DOI: 10.1097/MPH.0b013e3182050a4f
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289